This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $244.70 in the latest trading session, marking a +0.44% move from the prior day.
Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa
by Zacks Equity Research
Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa
Why Does the Stock of Cigna (CI) Look Attractive Now?
by Zacks Equity Research
The acquisition of Express Scripts by Cigna (CI) presents another major growth point for the company.
These 5 Companies are Earnings Perfection
by Tracey Ryniec
Looking for only the best this earnings season? These companies haven't missed on earnings in the last 5 years.
Dow Posts Longest Winning Run Since November: 5 Top Picks
by Nalak Das
The Dow - commenced 2019 on a brighter note. Positive developments on trade war front and Fed???s monetary stance are likely to boost investor sentiment in the near-term resulting in further consolidation of the index.
UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $239.62, marking a +1.17% move from the previous day.
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
Top Analyst Reports for UnitedHealth, CVS Health & General Electric
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), CVS Health (CVS) and General Electric (GE).
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $246.24 in the latest trading session, marking a +0.11% move from the prior day.
5 Worst Performing Stocks of Dow ETF Last Week
by Sweta Killa
Dow Jones suffered its worst week since the global financial crisis of 2008. We have highlighted five worst-performing stocks in the ETF.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $252.97, moving -1.98% from the previous trading session.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Will Lower Revenues Hurt BlackBerry's (BB) Q3 Earnings?
by Zacks Equity Research
BlackBerry (BB) is likely to report lower year-over-year revenues in the fiscal third quarter, primarily due to negative impact of the changes in the accounting and sales model.
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling
Healthcare Stocks Take a Hit on Texas ACA Ruling
by Mark Vickery
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.
Why the Earnings Surprise Streak Could Continue for UnitedHealth (UNH)
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $270.64, marking a +1.28% move from the previous day.
The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle
Top Analyst Reports for UnitedHealth, Broadcom & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Broadcom (AVGO) and CVS Health (CVS).
Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
A Tough Start to December as Stocks Slide Again
by David Borun
China, Brexit and generally uncertainty contribute to another decline in US equities
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $276.85, marking a -0.61% move from the previous day.
WellCare (WCG) Buys Aetna's Medicare Assets to Fuel Growth
by Zacks Equity Research
WellCare's (WCG) purchase of Medicare business of Aetna should lead to long-term growth.